Regeneron Pharmaceuticals, Inc.
Fusion polypeptides capable of activating receptors
Last updated:
Abstract:
A fusion polypeptide comprising (A).sub.x-M-(A').sub.y, wherein A and A' are each polypeptides capable of binding a target receptor. The fusion polypeptides of the invention form multimeric proteins which activate the target receptor. A and A' may be each be an antibody or fragment derived from an antibody specific for a target receptor, such as the same or different scFv fragments, and/or a ligand or ligand fragment or derivative capable of binding the target protein, M is a multimerizing component, and X and Y are independently a number between 1-10.
Status:
Grant
Type:
Utility
Filling date:
9 Nov 2017
Issue date:
1 Oct 2019